Joy et al. Disease activity rather than steroid use increases risk of diabetes in RA in BeST study over 10 years. @RheumNow #ACR22 Abstr#1987 https://t.co/VT2eb3Q4m9 https://t.co/kquZ70o9bU

• Prednisone Use and the Incidence of Hyperglycemia or Diabetes in Patients with …

L08 #ACR22 TIX/CIL (Evusheld) in Rheum Pts 157 pts, f/u 154 days 24 breakthrough COVID ifns (15%) 2 pts required hospitalization, rest had mild-mod symptoms No SAEs (CVD) @RheumNow

#ACR22 Best in PsA and SpA - new Rxs, unraveling responses to Rx by sex/gender. X-ray inhibition w SpA drugs is a reality. Nice peeps working in these areas @RheumNow @ACRheum https://t.co/8VfdyyHPZi

• https://twitter.com/uptotate/status/1592127498992631810

Here's the 1 year model #ACR22 @RheumNow https://t.co/VhEuJMMyIt

Eder et al. New PRESTO prediction model for PsA development in PsO. 1 year and 5 year models presented @RheumNow #ACR22 Abstr#1612 https://t.co/xMMVaIGnN5 https://t.co/RlJ3ZlEeDE

• Prediction of Psoriatic Arthritis Tool (PRESTO): Development and Performance of…

Krijbolder et al. TREAT EARLIER DBRCT. MTX vs PBO for pre-RA. Treat 1 year, stop, and follow 1 year. No difference in RA development. Delay in ACPA+ or high risk. Sustained benefit in MTX group on pain, EMS, function, MRI. @RheumNow #ACR22 Abstr#1603 https://t.co/M2qQfgrhC1 https://t.co/UUeknTLx0K

• Intervention with Methotrexate in Arthralgia at Risk for Rheumatoid Arthritis t…

Yazici et al. RCT of IA Lorecivivint for moderate/severe knee OA. CLK/DYRK inhibitor. No effect seen. @RheumNow #ACR22 Abstr#1899 https://t.co/XGQrMmNnSR https://t.co/rSJrT6Hms6

• A Phase 3, 28-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled T…

Bihlet et al. Anti-histamines may reduce structural progression of knee OA. Post-hoc analysis of 2 trials @RheumNow #ACR22 Abstr#1893 https://t.co/RrrelHDz75 https://t.co/Sf7RpjjAaN

• Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of…

Post-hoc analysis of SELECT-COMPARE showing decreased residual pain at week 12 but not week 26 cf. ADA, regardless of residual inflammation. Does this just reflect differing onset of action? @RheumNow ABST0297 #ACR22 https://t.co/9WyZAN3B16 https://t.co/fAC1bLw9EB

• Effect of Upadacitinib, Adalimumab, and Placebo on Residual Pain Among Patients…

Shanahan et al. RCT of Genicular nerve block for knee OA. It works but temporary, with loss of effect by week 12. @RheumNow #ACR22 Abstr#1892 https://t.co/VySjBGrVeR https://t.co/JNKQeOVB6z

• Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis:…

In a prospective cohort where MTX was withheld for 1 week post COVID vaccine, antibodies higher than other DMARDs which were continued (mostly RTX/MMF). Good to see more direct data rather than having to extrapolate from flu. @RheumNow ABST0913 #ACR22 https://t.co/YphKywNJfA

• Impact of Disease-modifying Antirheumatic Drugs on Immunogenicity to COVID-19 V…

Please find our Day 2 #ACR22 Daily Recap Video by @RheumNow Faculty https://t.co/f3BbKkgzRp @Janetbirdope @synovialjoints @doctorRBC @bella_mehta @AkhilSoodMD @RHEUMarampa @DrCassySims https://t.co/VZM53cUyWL

• Sunday (Day 2): ACR 22 Daily Recap | RheumNow

Ho et al. Consistent colchicine use assoc reduction in MACE in patients with gout and pre-existing CVD. @RheumNow #ACR22 Abstr#1815 https://t.co/tXwa2FrSrp https://t.co/8TKl4z7iaH

• Consistent Colchicine Use Is Associated with Decreased Major Adverse Cardiovasc…

Kastrati et al. Case series immune apheresis in IIM. 24 patients. Reduced CK in 21/24, 971 to 347. Reduced steroid 25%, median 12.5mg reduction @RheumNow #ACR22 Abstr#1882 https://t.co/UUlm4xEX61 https://t.co/bS2IA9OKnH

• Efficacy of Immune-apheresis in Patients with Inflammatory Myopathies: A Case S…

"If your partner won't use protection, close the vault!" - Dr. J Patricia Dhar interviewed on sexual Health and STD Prevention in Lupus Patients. Contact her pdhar@med.wayne.edu if you want to collaborate or fund her studies. #ACR22 @rheumnow https://t.co/WDLq9Mhoiw

• Addressing Sexual Health and STD Prevention in Lupus Patients | RheumNow